— Early sign of Alzheimer's reversed in lab — One of the earliest known impairments caused by Alzheimer's disease - loss of sense of smell - can be restored by removing a plaque-forming protein in a mouse model of the disease,…
— Parental controls on embryonic development? — When a sperm fertilises an egg, each contributes a set of chromosomes to the resulting embryo, which at these very early stages is called a zygote. Early on, zygotic genes are inert,…
— Newly discovered heart stem cells make muscle and bone — Researchers have identified a new and relatively abundant pool of stem cells in the heart. The findings in the December issue of Cell Stem Cell, a Cell Press publication, show that…
— BUSM researchers develop blood test to detect membranous nephropathy — Research conducted by a pair of physicians at Boston University School of Medicine (BUSM) and Boston Medical Centre (BMC) has led to the development of a test that can help diagnose…
— New hip implants no better than traditional implants — New hip implants appear to have no advantage over traditional implants, suggests a review of the evidence published on bmj.com today…
— Action needed to improve men's health in Europe — Policies aimed specifically at men are urgently needed to improve the health of Europe's men, say experts on bmj.com today…
— Probiotics reduce infections for patients in intensive care — Traumatic brain injury is associated with a profound suppression of the patient's ability to fight infection. At the same time the patient also often suffers hyper-inflammation, due…
— High blood sugar levels in older women linked to colorectal cancer — Elevated blood sugar levels are associated with an increased risk of colorectal cancer, according to a study led by researchers at Albert Einstein College of Medicine of Yeshiva University.…
— Engineered botulism toxins could have broader role in medicine — The most poisonous substance on Earth - already used medically in small doses to treat certain nerve disorders and facial wrinkles - could be re-engineered for an expanded role in helping…
A small subset of normal white blood cells gives rise to a rare leukaemia, study shows
New research has identified a small subset of normal white blood cells in the body that gives rise to a rare incurable form of leukaemia.
The study, led by investigators at The Ohio State University Comprehensive Cancer Centre - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James), shows that large granular lymphocyte leukaemia can occur in a small subset of white blood cells called NKT cells. NKT cells share features of immune cells called T lymphocytes and features of immune cells called natural killer (NK) cells.
The discovery, published online in the Journal of Clinical Investigation, arose from studies investigating why a mouse strain engineered to overexpress interleukin-15 often develops large granular lymphocyte leukaemia, a disease more common in Asia than the United States, and it points to new ways to prevent the malignancy.
The researchers show that, in mice and in humans, the novel subset of NKT cells responsible for large granular lymphocyte leukaemia are marked on their surface by a protein called NKp46. Only small numbers of these cells are present in mice and in humans. The study further shows that overexpression of interleukin-15 can drive these cells but not others to become leukaemic.
'These novel NKT cells represent a small white-blood-cell population in normal mice or healthy humans, but they have the potential to develop into large granular lymphocyte leukaemia under certain circumstances, such as a high interleukin-15 environment,' says first author Jianhua Yu, a research scientist with the OSUCCC - James.
'Our work suggests that targeting interleukin-15 signalling and NKp46 might offer a new way to prevent this leukaemia as we learn more about who is susceptible,' notes principal investigator Dr Michael A. Caligiuri, director of Ohio State's Comprehensive Cancer Centre and CEO of the James Cancer Hospital and Solove Research Institute. 'In fact, we show that using an antibody to block interleukin-15 prevents large granular lymphocyte leukaemia development in this mouse model.'
Or subscribe for our Newsletter, a free e-mail publication. It is published practically every day.
Discovery of cellular 'switch' may provide new means of triggering cell death, treating disease
A new type of stem cells found in prostate may be involved in cancer
Study reveals new genetic culprit in deadly skin cancer
New technique could eliminate inherited mitochondrial disease